• slider-dummy-1.jpg
  • image3.jpg
  • image4.jpg

Sandoz is a world leader in generic pharmaceuticals, finding innovative ways to making medicines affordable and accessible to more than 90 percent of the world’s population.

Learn more about our company
Visions and Values


Sandoz Germany launches innovative new topical therapy for erectile dysfunction, a leading urological disorder

August 18, 2014

Sandoz, the generic pharmaceuticals division of Novartis, today announces the launch in Germany of Vitaros®, an innovative new topical therapy for erectile dysfunction (ED), one of the leading urological disorders in Europe and worldwide. Earlier this month, Sandoz launched Vitaros in Sweden.


Our people are our greatest resource. We are always looking for new colleagues to share in our commitment to make the world a healthier place.

Learn more about careers at Sandoz

Watch our Sandoz TV video series to discover more about the world of Sandoz and generics.

Visit our multimedia gallery to watch the latest episode



We have collected the most important and frequently asked questions about our business.

Visit our frequently asked questions page